 | • レポートコード：MRC2312MG09545 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、72ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の経口用コルヒチン市場規模と予測を収録しています。・世界の経口用コルヒチン市場：売上、2018年-2023年、2024年-2029年 ・世界の経口用コルヒチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の経口用コルヒチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口錠剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 経口用コルヒチンのグローバル主要企業は、Hikma Pharmaceuticals、 Takeda Pharmaceuticals、 Viatris、 ROMEG Therapeutics、 Major Pharmaceuticals、 Zydus Pharmaceuticals、 Par Pharmaceuticals、 KPC Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、経口用コルヒチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の経口用コルヒチン市場：タイプ別、2018年-2023年、2024年-2029年 世界の経口用コルヒチン市場：タイプ別市場シェア、2022年 ・経口錠剤、経口カプセル、経口液剤 世界の経口用コルヒチン市場：用途別、2018年-2023年、2024年-2029年 世界の経口用コルヒチン市場：用途別市場シェア、2022年 ・痛風、家族性地中海熱（FMF）、心膜炎、その他 世界の経口用コルヒチン市場：地域・国別、2018年-2023年、2024年-2029年 世界の経口用コルヒチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における経口用コルヒチンのグローバル売上、2018年-2023年 ・主要企業における経口用コルヒチンのグローバル売上シェア、2022年 ・主要企業における経口用コルヒチンのグローバル販売量、2018年-2023年 ・主要企業における経口用コルヒチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Hikma Pharmaceuticals、 Takeda Pharmaceuticals、 Viatris、 ROMEG Therapeutics、 Major Pharmaceuticals、 Zydus Pharmaceuticals、 Par Pharmaceuticals、 KPC Pharmaceuticals ************************************************************* ・調査・分析レポートの概要 経口用コルヒチン市場の定義 市場セグメント 世界の経口用コルヒチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の経口用コルヒチン市場規模 世界の経口用コルヒチン市場規模：2022年 VS 2029年 世界の経口用コルヒチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの経口用コルヒチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の経口用コルヒチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：経口錠剤、経口カプセル、経口液剤 経口用コルヒチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：痛風、家族性地中海熱（FMF）、心膜炎、その他 経口用コルヒチンの用途別グローバル売上・予測 ・地域別市場分析 地域別経口用コルヒチン市場規模 2022年と2029年 地域別経口用コルヒチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Hikma Pharmaceuticals、 Takeda Pharmaceuticals、 Viatris、 ROMEG Therapeutics、 Major Pharmaceuticals、 Zydus Pharmaceuticals、 Par Pharmaceuticals、 KPC Pharmaceuticals ... |
This research report provides a comprehensive analysis of the Oral Colchicine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Oral Colchicine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Oral Colchicine, challenges faced by the industry, and potential opportunities for market players.
The global Oral Colchicine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Oral Colchicine market presents opportunities for various stakeholders, including Gout, Familial Mediterranean Fever (FMF). Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Oral Colchicine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Oral Colchicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Oral Colchicine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Oral Colchicine market.
Market Overview: The report provides a comprehensive overview of the Oral Colchicine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Oral Tablet, Oral Capsule), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Oral Colchicine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Oral Colchicine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Oral Colchicine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Oral Colchicine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Oral Colchicine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Oral Colchicine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Oral Colchicine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Oral Colchicine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Oral Colchicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Oral Tablet
Oral Capsule
Oral Solution
Market segment by Application
Gout
Familial Mediterranean Fever (FMF)
Pericarditis
Others
Global Oral Colchicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Hikma Pharmaceuticals
Takeda Pharmaceuticals
Viatris
ROMEG Therapeutics
Major Pharmaceuticals
Zydus Pharmaceuticals
Par Pharmaceuticals
KPC Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Colchicine, market overview.
Chapter 2: Global Oral Colchicine market size in revenue and volume.
Chapter 3: Detailed analysis of Oral Colchicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Colchicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral Colchicine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Oral Colchicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Colchicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Colchicine Overall Market Size
2.1 Global Oral Colchicine Market Size: 2022 VS 2029
2.2 Global Oral Colchicine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Oral Colchicine Sales: 2018-2029
3 Company Landscape
3.1 Top Oral Colchicine Players in Global Market
3.2 Top Global Oral Colchicine Companies Ranked by Revenue
3.3 Global Oral Colchicine Revenue by Companies
3.4 Global Oral Colchicine Sales by Companies
3.5 Global Oral Colchicine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oral Colchicine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oral Colchicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral Colchicine Players in Global Market
3.8.1 List of Global Tier 1 Oral Colchicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Colchicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Oral Colchicine Market Size Markets, 2022 & 2029
4.1.2 Oral Tablet
4.1.3 Oral Capsule
4.1.4 Oral Solution
4.2 By Type – Global Oral Colchicine Revenue & Forecasts
4.2.1 By Type – Global Oral Colchicine Revenue, 2018-2023
4.2.2 By Type – Global Oral Colchicine Revenue, 2024-2029
4.2.3 By Type – Global Oral Colchicine Revenue Market Share, 2018-2029
4.3 By Type – Global Oral Colchicine Sales & Forecasts
4.3.1 By Type – Global Oral Colchicine Sales, 2018-2023
4.3.2 By Type – Global Oral Colchicine Sales, 2024-2029
4.3.3 By Type – Global Oral Colchicine Sales Market Share, 2018-2029
4.4 By Type – Global Oral Colchicine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oral Colchicine Market Size, 2022 & 2029
5.1.2 Gout
5.1.3 Familial Mediterranean Fever (FMF)
5.1.4 Pericarditis
5.1.5 Others
5.2 By Application – Global Oral Colchicine Revenue & Forecasts
5.2.1 By Application – Global Oral Colchicine Revenue, 2018-2023
5.2.2 By Application – Global Oral Colchicine Revenue, 2024-2029
5.2.3 By Application – Global Oral Colchicine Revenue Market Share, 2018-2029
5.3 By Application – Global Oral Colchicine Sales & Forecasts
5.3.1 By Application – Global Oral Colchicine Sales, 2018-2023
5.3.2 By Application – Global Oral Colchicine Sales, 2024-2029
5.3.3 By Application – Global Oral Colchicine Sales Market Share, 2018-2029
5.4 By Application – Global Oral Colchicine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Oral Colchicine Market Size, 2022 & 2029
6.2 By Region – Global Oral Colchicine Revenue & Forecasts
6.2.1 By Region – Global Oral Colchicine Revenue, 2018-2023
6.2.2 By Region – Global Oral Colchicine Revenue, 2024-2029
6.2.3 By Region – Global Oral Colchicine Revenue Market Share, 2018-2029
6.3 By Region – Global Oral Colchicine Sales & Forecasts
6.3.1 By Region – Global Oral Colchicine Sales, 2018-2023
6.3.2 By Region – Global Oral Colchicine Sales, 2024-2029
6.3.3 By Region – Global Oral Colchicine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Oral Colchicine Revenue, 2018-2029
6.4.2 By Country – North America Oral Colchicine Sales, 2018-2029
6.4.3 US Oral Colchicine Market Size, 2018-2029
6.4.4 Canada Oral Colchicine Market Size, 2018-2029
6.4.5 Mexico Oral Colchicine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Oral Colchicine Revenue, 2018-2029
6.5.2 By Country – Europe Oral Colchicine Sales, 2018-2029
6.5.3 Germany Oral Colchicine Market Size, 2018-2029
6.5.4 France Oral Colchicine Market Size, 2018-2029
6.5.5 U.K. Oral Colchicine Market Size, 2018-2029
6.5.6 Italy Oral Colchicine Market Size, 2018-2029
6.5.7 Russia Oral Colchicine Market Size, 2018-2029
6.5.8 Nordic Countries Oral Colchicine Market Size, 2018-2029
6.5.9 Benelux Oral Colchicine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Oral Colchicine Revenue, 2018-2029
6.6.2 By Region – Asia Oral Colchicine Sales, 2018-2029
6.6.3 China Oral Colchicine Market Size, 2018-2029
6.6.4 Japan Oral Colchicine Market Size, 2018-2029
6.6.5 South Korea Oral Colchicine Market Size, 2018-2029
6.6.6 Southeast Asia Oral Colchicine Market Size, 2018-2029
6.6.7 India Oral Colchicine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Oral Colchicine Revenue, 2018-2029
6.7.2 By Country – South America Oral Colchicine Sales, 2018-2029
6.7.3 Brazil Oral Colchicine Market Size, 2018-2029
6.7.4 Argentina Oral Colchicine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Oral Colchicine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Oral Colchicine Sales, 2018-2029
6.8.3 Turkey Oral Colchicine Market Size, 2018-2029
6.8.4 Israel Oral Colchicine Market Size, 2018-2029
6.8.5 Saudi Arabia Oral Colchicine Market Size, 2018-2029
6.8.6 UAE Oral Colchicine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Hikma Pharmaceuticals
7.1.1 Hikma Pharmaceuticals Company Summary
7.1.2 Hikma Pharmaceuticals Business Overview
7.1.3 Hikma Pharmaceuticals Oral Colchicine Major Product Offerings
7.1.4 Hikma Pharmaceuticals Oral Colchicine Sales and Revenue in Global (2018-2023)
7.1.5 Hikma Pharmaceuticals Key News & Latest Developments
7.2 Takeda Pharmaceuticals
7.2.1 Takeda Pharmaceuticals Company Summary
7.2.2 Takeda Pharmaceuticals Business Overview
7.2.3 Takeda Pharmaceuticals Oral Colchicine Major Product Offerings
7.2.4 Takeda Pharmaceuticals Oral Colchicine Sales and Revenue in Global (2018-2023)
7.2.5 Takeda Pharmaceuticals Key News & Latest Developments
7.3 Viatris
7.3.1 Viatris Company Summary
7.3.2 Viatris Business Overview
7.3.3 Viatris Oral Colchicine Major Product Offerings
7.3.4 Viatris Oral Colchicine Sales and Revenue in Global (2018-2023)
7.3.5 Viatris Key News & Latest Developments
7.4 ROMEG Therapeutics
7.4.1 ROMEG Therapeutics Company Summary
7.4.2 ROMEG Therapeutics Business Overview
7.4.3 ROMEG Therapeutics Oral Colchicine Major Product Offerings
7.4.4 ROMEG Therapeutics Oral Colchicine Sales and Revenue in Global (2018-2023)
7.4.5 ROMEG Therapeutics Key News & Latest Developments
7.5 Major Pharmaceuticals
7.5.1 Major Pharmaceuticals Company Summary
7.5.2 Major Pharmaceuticals Business Overview
7.5.3 Major Pharmaceuticals Oral Colchicine Major Product Offerings
7.5.4 Major Pharmaceuticals Oral Colchicine Sales and Revenue in Global (2018-2023)
7.5.5 Major Pharmaceuticals Key News & Latest Developments
7.6 Zydus Pharmaceuticals
7.6.1 Zydus Pharmaceuticals Company Summary
7.6.2 Zydus Pharmaceuticals Business Overview
7.6.3 Zydus Pharmaceuticals Oral Colchicine Major Product Offerings
7.6.4 Zydus Pharmaceuticals Oral Colchicine Sales and Revenue in Global (2018-2023)
7.6.5 Zydus Pharmaceuticals Key News & Latest Developments
7.7 Par Pharmaceuticals
7.7.1 Par Pharmaceuticals Company Summary
7.7.2 Par Pharmaceuticals Business Overview
7.7.3 Par Pharmaceuticals Oral Colchicine Major Product Offerings
7.7.4 Par Pharmaceuticals Oral Colchicine Sales and Revenue in Global (2018-2023)
7.7.5 Par Pharmaceuticals Key News & Latest Developments
7.8 KPC Pharmaceuticals
7.8.1 KPC Pharmaceuticals Company Summary
7.8.2 KPC Pharmaceuticals Business Overview
7.8.3 KPC Pharmaceuticals Oral Colchicine Major Product Offerings
7.8.4 KPC Pharmaceuticals Oral Colchicine Sales and Revenue in Global (2018-2023)
7.8.5 KPC Pharmaceuticals Key News & Latest Developments
8 Global Oral Colchicine Production Capacity, Analysis
8.1 Global Oral Colchicine Production Capacity, 2018-2029
8.2 Oral Colchicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Colchicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral Colchicine Supply Chain Analysis
10.1 Oral Colchicine Industry Value Chain
10.2 Oral Colchicine Upstream Market
10.3 Oral Colchicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Colchicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer